Archive

Intensive weight loss programme improves eating disorder symptoms in people with Type 2 Diabetes at risk of eating disorders, Oxford study finds

Written by | 15 Jun 2025

An intensive low-energy diet programme, similar to the NHS Type 2 Diabetes Path to Remission, significantly improved eating disorder symptoms in people with type 2 diabetes and excess weight who […]

GLP-1 RA medications safe and effective for treating obesity in adults with mental illness

Written by | 25 May 2025

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive […]

First head-to-head study in people living with obesity shows tirzepatide results in around 50% more weight loss than semaglutide

Written by | 18 May 2025

A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an […]

New oral GLP-1RA orforglipron comparable to semaglutide for weight loss

Written by | 22 Apr 2025

Results from the ACHIEVE-1 trial show that treatment with orforglipron was associated with weight loss ranging from 4.7 – 7.9% (4.4 – 7.3 Kg) of body weight in […]

Study finds women much more likely to be aware of and have good understanding of obesity drugs

Written by | 21 Apr 2025

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that women are much more aware of knowledgeable about […]

Expanding access to anti-obesity medications delivers 13% return on investment for society

Written by | 31 Mar 2025

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a substantial societal return […]

Most older adults say Medicare and other insurance should cover obesity drugs, and many show interest in using them

Written by | 30 Mar 2025

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study. And more […]

Obesity Action Coalition & The Obesity Society send letter to FDA on behalf of more than 20 leading organizations & providers urging enforcement of compounding regulations

Written by | 25 Mar 2025

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading […]

GLP-1 RAs – where are we now? What have we learned?

Written by | 17 Mar 2025

Pharmacist Deborah Evans runs a weight-management clinic at Remedi Health in Winchester. She has helped many people to lose weight and improve their health using the GLP-1 receptor […]

Fizzy water might aid weight loss by boosting glucose uptake and metabolism

Written by | 31 Jan 2025

Fizzy water might aid weight loss by boosting blood glucose uptake and metabolism—the rate at which the body uses and converts energy—but the effects are so small, drinking […]

GLP-1 RA drugs effectively treat obesity in adults without diabetes

Written by | 7 Jan 2025

A meta- analysis of studies evaluating the efficacy and safety of various glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for treating obesity in adults without diabetes, suggests […]

Nearly half of U.S. adults resolve to start a new diet in 2025

Written by | 1 Jan 2025

Nearly half of U.S. adults say starting a new diet is one of their New Year’s resolutions, according to a new Physicians Committee for Responsible Medicine/Morning Consult survey. Of […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.